Surveillance Research Program
What is a Cancer Registry?
SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-based cancer statistics.
Visit the Toward Precision Cancer Surveillance Blog
Cancer Trends Progress Report
The report, intended for policy makers, researchers, and public health professionals, includes key measures of progress along the cancer control continuum and uses national trend data to illustrate where improvements have been made.
Cancer Trends Progress ReportVisit CTPR
Annual Report to the Nation on the Status of Cancer
An update of rates for new cases, deaths, and trends for the most common cancers in the United States. This year's Special Section focuses on cancer trends among adults ages 20 to 49.
Annual Report to the Nation on the Status of CancerVisit ARN
SEER*Explorer – New Tool to Explore SEER Statistics
Access a wide range of cancer statistics organized by cancer site and by demographic characteristics.
SEER*ExplorerVisit SEER*Explorer
Announcements
- Funding Opportunity: Cancer Intervention and Surveillance Modeling Network (CISNET)
- Pre-application webinar (11/4/19 12-1:30 pm ET) - [Recording
] [Slides (PDF, 566 KB) ] - Questions and Answers (PDF, 116 KB)
- Pre-application webinar (11/4/19 12-1:30 pm ET) - [Recording
- Fall 2019 Newsletter (PDF, 5.9 MB)
- Funding Opportunity: Integration of Individual Residential Histories into Cancer Research
- Funding Opportunity: Leveraging Population-based Cancer Registry Data to Study Health Disparities
Data Releases
Job Opportunities
- Cancer Research Training Award Fellows sought for:
In the News
- SEER Data used to Identify Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer—ATS: Annals of the American Thoracic Society Tweet
- SEER data used to capture the state of lung cancer in the US—American Lung Association Tweet
- Researchers use SEER-Medicare linked data to assess racial disparities in the treatment and outcomes of patients with multiple myeloma—ASH Publications Tweet